Erbo Dong1, Svetlana G Dzitoyeva2, Francesco Matrisciano2, Patricia Tueting2, Dennis R Grayson2, Alessandro Guidotti2. 1. Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, Illinois. Electronic address: Edong@psych.uic.edu. 2. Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Abstract
BACKGROUND: Prenatal stress (PRS) is considered a risk factor for several neurodevelopmental disorders including schizophrenia (SZ). An animal model involving restraint stress of pregnant mice suggests that PRS induces epigenetic changes in specific GABAergic and glutamatergic genes likely to be implicated in SZ, including the gene for brain-derived neurotrophic factor (BDNF). METHODS: Studying adult offspring of pregnant mice subjected to PRS, we explored the long-term effects of PRS on behavior and on the expression of key chromatin remodeling factors including DNA methyltransferase 1, ten-eleven-translocation hydroxylases, methyl CpG binding protein 2, histone deacetylases, and histone methyltransferases and demethylase in the frontal cortex and hippocampus. We also measured the expression of BDNF. RESULTS: Adult PRS offspring demonstrate behavioral abnormalities suggestive of SZ and molecular changes similar to changes seen in postmortem brains of patients with SZ. This includes a significant increase in DNA methyltransferase 1 and ten-eleven-translocation hydroxylase 1 in the frontal cortex and hippocampus but not in cerebellum; no changes in histone deacetylases, histone methyltransferases and demethylases, or methyl CpG binding protein 2, and a significant decrease in Bdnf messenger RNA variants. The decrease of the corresponding Bdnf transcript level was accompanied by an enrichment of 5-methylcytosine and 5-hydroxymethylcytosine at Bdnf gene regulatory regions. In addition, the expression of Bdnf transcripts (IV and IX) correlated positively with social approach in both PRS mice and nonstressed mice. CONCLUSIONS: Because patients with psychosis and PRS mice show similar epigenetic signature, PRS mice may be a suitable model for understanding the behavioral and molecular epigenetic changes observed in patients with SZ.
BACKGROUND: Prenatal stress (PRS) is considered a risk factor for several neurodevelopmental disorders including schizophrenia (SZ). An animal model involving restraint stress of pregnant mice suggests that PRS induces epigenetic changes in specific GABAergic and glutamatergic genes likely to be implicated in SZ, including the gene for brain-derived neurotrophic factor (BDNF). METHODS: Studying adult offspring of pregnant mice subjected to PRS, we explored the long-term effects of PRS on behavior and on the expression of key chromatin remodeling factors including DNA methyltransferase 1, ten-eleven-translocation hydroxylases, methyl CpG binding protein 2, histone deacetylases, and histone methyltransferases and demethylase in the frontal cortex and hippocampus. We also measured the expression of BDNF. RESULTS: Adult PRS offspring demonstrate behavioral abnormalities suggestive of SZ and molecular changes similar to changes seen in postmortem brains of patients with SZ. This includes a significant increase in DNA methyltransferase 1 and ten-eleven-translocation hydroxylase 1 in the frontal cortex and hippocampus but not in cerebellum; no changes in histone deacetylases, histone methyltransferases and demethylases, or methyl CpG binding protein 2, and a significant decrease in Bdnf messenger RNA variants. The decrease of the corresponding Bdnf transcript level was accompanied by an enrichment of 5-methylcytosine and 5-hydroxymethylcytosine at Bdnf gene regulatory regions. In addition, the expression of Bdnf transcripts (IV and IX) correlated positively with social approach in both PRSmice and nonstressed mice. CONCLUSIONS: Because patients with psychosis and PRSmice show similar epigenetic signature, PRSmice may be a suitable model for understanding the behavioral and molecular epigenetic changes observed in patients with SZ.
Authors: Hamid Mostafavi Abdolmaleky; Kuang-hung Cheng; Andrea Russo; Cassandra L Smith; Stephen V Faraone; Marsha Wilcox; Rahim Shafa; Stephen J Glatt; Giang Nguyen; Joe F Ponte; Sam Thiagalingam; Ming T Tsuang Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2005-04-05 Impact factor: 3.568
Authors: Marin Veldic; Bashkim Kadriu; Ekrem Maloku; Roberto C Agis-Balboa; Alessandro Guidotti; John M Davis; Erminio Costa Journal: Schizophr Res Date: 2007-01-31 Impact factor: 4.939
Authors: Victoria Valinluck; Hsin-Hao Tsai; Daniel K Rogstad; Artur Burdzy; Adrian Bird; Lawrence C Sowers Journal: Nucleic Acids Res Date: 2004-08-09 Impact factor: 16.971
Authors: Melisa C Monteleone; María Eugenia Pallarés; Silvia C Billi; Marta C Antonelli; Marcela A Brocco Journal: J Mol Neurosci Date: 2018-06-22 Impact factor: 3.444
Authors: Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger Journal: Nat Rev Drug Discov Date: 2016-03-04 Impact factor: 84.694
Authors: Tomoaki Ito; Harumi Saeki; Xin Guo; Polina Sysa-Shah; Jonathan Coulter; Kellie L K Tamashiro; Richard S Lee; Hajime Orita; Koichi Sato; Shun Ishiyama; Alicia Hulbert; William E Smith; Lisa A Peterson; Malcolm V Brock; Kathleen L Gabrielson Journal: Carcinogenesis Date: 2020-12-31 Impact factor: 4.944